Comparative Study of the Mutations Observed in the SARS-CoV-2 RBD Variants of Concern and Their Impact on the

Mariem Ghoula1, Audrey Deyawe Kongmeneck1, Rita Eid1

  • 1Université de Paris, CNRS, INSERM, Unité de Biologie Fonctionnelle et Adaptative, F-75013 Paris, France.

PubMed

Insights

New SARS-CoV-2 variants exhibit increased ACE2 binding affinity and potential antibody evasion. Key mutations in the spike protein

Area of Science:

  • Virology
  • Structural Biology
  • Computational Biology

Background:

  • The emergence of SARS-CoV-2 variants of concern (VOCs) significantly impacts COVID-19's global health burden.
  • The spike protein's receptor-binding domain (RBD) is crucial for viral entry and a key target for therapeutic interventions.
  • Genetic variations in SARS-CoV-2, particularly in the spike protein, can alter viral properties like transmissibility and virulence.

Purpose of the Study:

  • To investigate the structural and biophysical changes in SARS-CoV-2 VOCs affecting ACE2 binding and antibody evasion.
  • To identify specific amino acid residues responsible for altered viral affinity and immune escape mechanisms.
  • To compare the binding characteristics of different SARS-CoV-2 variants with the human ACE2 receptor.

Main Methods:

  • Reconstruction of various SARS-CoV-2 variants of concern.
  • Molecular dynamics (MD) simulations to analyze the stability of the ACE2-RBD complex.
  • Free energy calculations to assess binding affinities and biophysical properties.
  • Detailed structural analysis of key residues within the RBD.

Main Results:

  • SARS-CoV-2 VOCs demonstrate a higher binding affinity to ACE2 compared to the ancestral Wuhan strain.
  • Specific mutations, including K417N and E484K/A, are implicated in antibody evasion.
  • Mutations Q498R and N501Y enhance the RBD's affinity for ACE2, potentially increasing viral infectivity.
  • Identification of crucial residues maintaining a balance between ACE2 affinity and antibody evasion.

Conclusions:

  • SARS-CoV-2 variants possess enhanced binding to ACE2, contributing to their increased prevalence.
  • Understanding these structural and functional changes is vital for developing effective antiviral strategies and vaccines.
  • Targeting specific mutations may offer a pathway to counter the evolution of SARS-CoV-2 VOCs.

Related Concept Videos

Viral Mutations00:36

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
32.4K
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.2K
Mutations in Microorganisms01:18

Mutations in Microorganisms

Mutations are heritable changes in an organism’s genome involving alterations in the base sequence of DNA or RNA. These changes can influence cellular processes and phenotypic traits, potentially transforming the unaltered wild type into a mutant form. Such changes, termed forward mutations, are pivotal in shaping the genetic diversity of organisms.RNA viruses exhibit the highest mutation rates due to the absence of robust proofreading mechanisms during genome replication. In contrast,...
29
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.1K
Leaky Scanning02:28

Leaky Scanning

During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.2K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.3K